Joule Biotechnologies Raises $30 Million
Joule Biotechnologies, a Cambridge, Mass.-based developer of technology to convert carbon dioxide into ethanol, has raised $30 million in Series B funding led by Flagship Ventures.
27 April 2010•3 mins read
Joule Biotechnologies, a Cambridge, Mass.-based developer of technology to convert carbon dioxide into ethanol, has raised $30 million in Series B funding led by Flagship Ventures.
